OPKO Health, Inc. Other Revenue, Net (Deprecated 2018-01-31)
OPKO Health, Inc. (OPK) reported Other Revenue, Net (Deprecated 2018-01-31) of $300.00 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2013-03-18
- OPKO Health, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $300.00K, a 538.30% increase year-over-year.
- OPKO Health, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $294.00K, a 2350.00% increase year-over-year.
- OPKO Health, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $138.00K, a 961.54% increase year-over-year.
- OPKO Health, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $63.00K.
- OPKO Health, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2011 was $135.00K, a 97.99% decline from fiscal 2010.
- OPKO Health, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2010 was $6.73M.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-09-30 | $300.00K 10-Q · filed 2012-11-09 | $594.00K derived: sum of 2 quarters · filed 2012-11-09 | $732.00K 10-Q · filed 2012-11-09 | $795.00K derived: sum of 4 quarters · filed 2012-11-09 |
| 2012-06-30 | $294.00K 10-Q · filed 2012-08-09 | $432.00K 10-Q · filed 2012-08-09 | $495.00K derived: sum of 3 quarters · filed 2012-08-09 | $542.00K derived: sum of 4 quarters · filed 2012-08-09 |
| 2012-03-31 | $138.00K 10-Q · filed 2012-05-10 | $201.00K derived: sum of 2 quarters · filed 2012-05-10 | $248.00K derived: sum of 3 quarters · filed 2012-05-10 | $260.00K derived: sum of 4 quarters · filed 2012-05-10 |
| 2011-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $110.00K derived: sum of 2 quarters · filed 2012-03-15 | $122.00K derived: sum of 3 quarters · filed 2012-03-15 | $135.00K 10-K · filed 2012-03-15 |
| 2011-09-30 | $47.00K 10-Q · filed 2012-11-09 | $59.00K derived: sum of 2 quarters · filed 2011-11-09 | $72.00K 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $12.00K 10-Q · filed 2011-08-08 | $25.00K 10-Q · filed 2011-08-08 | ||
| 2011-03-31 | $13.00K derived: 10-K 12 month − 3 quarters · filed 2012-03-15 | |||
| 2010-12-31 | $6.73M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |